Monthly revenue and year-on-year change for MOMO (8454) and Navicare Biotech (8472) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.
Year-on-year change
Monthly revenue history
| Month | MOMO | YoY | Navicare Biotech | YoY |
|---|---|---|---|---|
| Oct 2026 | NT$8.09 billion | +3.8% | NT$51.5 million | +0.8% |
| Sep 2026 | NT$8.59 billion | +8.2% | NT$45.2 million | -28.1% |
| Aug 2026 | NT$9.15 billion | +7.8% | NT$55.6 million | +121.3% |
| Jul 2026 | NT$8.55 billion | +5.2% | NT$48.1 million | +5.6% |
| Jun 2026 | NT$9.82 billion | +6.5% | NT$47.5 million | -20.7% |
| May 2026 | NT$8.99 billion | +4.1% | NT$38.6 million | +7.3% |
| Apr 2026 | NT$8.28 billion | +1.3% | NT$39.8 million | -11.8% |
| Mar 2026 | NT$9.14 billion | +2.1% | NT$47.3 million | +11.1% |
| Feb 2026 | NT$8.13 billion | -2.1% | NT$47 million | +202.3% |
| Jan 2026 | NT$9.32 billion | +1.9% | NT$28.5 million | +30.8% |
| Dec 2025 | NT$9.2 billion | -5.7% | NT$41.3 million | +39.8% |
| Nov 2025 | NT$14.68 billion | -5.7% | NT$30.9 million | -4.8% |
| Oct 2025 | NT$7.8 billion | -4.4% | NT$51 million | +128.1% |
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16